Keith Wayne Ward - Net Worth and Insider Trading
Keith Wayne Ward Net Worth
The estimated net worth of Keith Wayne Ward is at least $1 Million dollars as of 2024-09-30. Keith Wayne Ward is the Chief Development Officer of Reata Pharmaceuticals Inc and owns about 8,620 shares of Reata Pharmaceuticals Inc (RETA) stock worth over $1 Million. Details can be seen in Keith Wayne Ward's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Keith Wayne Ward has not made any transactions after 2019-02-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Keith Wayne Ward
Keith Wayne Ward Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Keith Wayne Ward owns 2 companies in total, including Reata Pharmaceuticals Inc (RETA) , and Skye Bioscience Inc (SKYE) .
Click here to see the complete history of Keith Wayne Ward’s form 4 insider trades.
Insider Ownership Summary of Keith Wayne Ward
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RETA | Reata Pharmaceuticals Inc | 2019-02-26 | See Remarks |
| SKYE | Skye Bioscience Inc | 2021-12-14 | director |
Keith Wayne Ward Latest Holdings Summary
Keith Wayne Ward currently owns a total of 1 stock. Keith Wayne Ward owns 8,620 shares of Reata Pharmaceuticals Inc (RETA) as of February 26, 2019, with a value of $1 Million.
Latest Holdings of Keith Wayne Ward
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RETA | Reata Pharmaceuticals Inc | 2019-02-26 | 8,620 | 172.36 | 1,485,743 |
Holding Weightings of Keith Wayne Ward
Keith Wayne Ward Form 4 Trading Tracker
According to the SEC Form 4 filings, Keith Wayne Ward has made a total of 0 transactions in Reata Pharmaceuticals Inc (RETA) over the past 5 years. The most-recent trade in Reata Pharmaceuticals Inc is the sale of 40,367 shares on February 26, 2019, which brought Keith Wayne Ward around $4 Million.
Insider Trading History of Keith Wayne Ward
- 1
Keith Wayne Ward Trading Performance
Keith Wayne Ward Ownership Network
Keith Wayne Ward Owned Company Details
What does Reata Pharmaceuticals Inc do?
Who are the key executives at Reata Pharmaceuticals Inc?
Keith Wayne Ward is the See Remarks of Reata Pharmaceuticals Inc. Other key executives at Reata Pharmaceuticals Inc include director & 10 percent owner Antal Rohit Desai , SVP & Chief Accounting Officer Bhaskar Anand , and EVP & Chief R&D Officer Rajiv Patni .
Reata Pharmaceuticals Inc (RETA) Insider Trades Summary
Over the past 18 months, Keith Wayne Ward made no insider transaction in Reata Pharmaceuticals Inc (RETA). Other recent insider transactions involving Reata Pharmaceuticals Inc (RETA) include a net sale of 181,683 shares made by Manmeet Singh Soni , a net sale of 42,516 shares made by Dawn Carter Bir , and a net sale of 1,895 shares made by Bhaskar Anand .
In summary, during the past 3 months, insiders sold 0 shares of Reata Pharmaceuticals Inc (RETA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 261,799 shares of Reata Pharmaceuticals Inc (RETA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 261,799 shares.
Reata Pharmaceuticals Inc (RETA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Reata Pharmaceuticals Inc Insider Transactions
Keith Wayne Ward Mailing Address
Above is the net worth, insider trading, and ownership report for Keith Wayne Ward. You might contact Keith Wayne Ward via mailing address: 11217 Jonas Ridge Lane, Raleigh Nc 27613.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
